Single-inhaler fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol plus umeclidinium using two inhalers for chronic obstructive pulmonary disease: a randomized non-inferiority study.
about
Patient considerations in the treatment of COPD: focus on the new combination inhaler fluticasone furoate/umeclidinium/vilanterol.Ginseng Compatibility Environment Attenuates Toxicity and Keeps Efficacy in Cor Pulmonale Treated by Fuzi Beimu Incompatibility Through the Coordinated Crosstalk of PKA and Epac Signaling Pathways.Effect of background long-acting beta-agonist therapy on the efficacy and safety of a novel, nebulized glycopyrrolate in subjects with moderate-to-very-severe COPD
P2860
Single-inhaler fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol plus umeclidinium using two inhalers for chronic obstructive pulmonary disease: a randomized non-inferiority study.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Single-inhaler fluticasone fur ...... domized non-inferiority study.
@en
Single-inhaler fluticasone fur ...... domized non-inferiority study.
@nl
type
label
Single-inhaler fluticasone fur ...... domized non-inferiority study.
@en
Single-inhaler fluticasone fur ...... domized non-inferiority study.
@nl
prefLabel
Single-inhaler fluticasone fur ...... domized non-inferiority study.
@en
Single-inhaler fluticasone fur ...... domized non-inferiority study.
@nl
P2093
P2860
P1433
P1476
Single-inhaler fluticasone fur ...... domized non-inferiority study.
@en
P2093
Afisi S Ismaila
Chang-Qing Zhu
Noushin Brealey
Peter R Bremner
P2860
P2888
P356
10.1186/S12931-018-0724-0
P577
2018-01-25T00:00:00Z
P6179
1100620604